Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tenagril
- Development stage
- Unknown
- Lead developer
- 3Sixty Biomedicine
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Tenagril is a natural, complementary and alternative medicine (CAM) supplement developed by 3Sixty Biomedicine for the prevention and relief of migraine symptoms. The primary active ingredient in Tenagril is a standardized extract of *Tanacetum parthenium* (Feverfew), which contains parthenolide as its key bioactive compound. Feverfew is traditionally used for its anti-inflammatory and vasodilatory properties. Tenagril is believed to work by inhibiting the release of serotonin and reducing the synthesis of inflammatory prostaglandins, thereby addressing the neurovascular dysregulation and blood vessel dilation associated with migraine pathology. It is marketed as a daily prophylactic capsule to reduce the frequency and severity of migraine attacks, as well as associated symptoms like nausea and vomiting.
- Brand names
- Tenagril
- Other names
- feverfew extracttanacetum parthenium extract
02
Targets
IKBKB (IKKβ)RELA (Nuclear Factor Kappa B Subunit p65)
Beyond the preview
Go deeper on Tenagril.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tenagril.